Press releases
- Catalent, Inc. Investor Warning: 4/25/2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
- CATALENT, INC. INVESTORS: April 25, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
- Catalent, Inc. to Present at March Investor Conferences
- Catalent Appoints Sridhar Krishnan to Lead New Global Operational Excellence Strategy, “The Catalent Way”
- Catalent Publishes Fourth Annual Corporate Responsibility Report Highlighting Achievements While Providing New Record Number of Patient Treatments
- Catalent Appoints Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary
- Catalent, Inc. Reports Second Quarter Fiscal 2023 Results
- Catalent, Inc. Announces Second Quarter Fiscal Year 2023 Earnings Conference Webcast
- Catalent Appoints Ricardo Zayas as North American Biologics Operations Leader
- Sarepta and Catalent Expand Strategic Manufacturing Partnership With Commercial Supply Agreement for Duchenne Muscular Dystrophy Gene Therapy Candidate
More ▼
Key statistics
As of last trade, Catalent Inc (0C8:BER) traded at 59.44, 50.71% above the 52 week low of 39.44 set on Nov 28, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 59.44 |
---|---|
High | 59.44 |
Low | 59.44 |
Bid | 62.39 |
Offer | 62.60 |
Previous close | 57.43 |
Average volume | 147.90 |
---|---|
Shares outstanding | 180.09m |
Free float | 179.31m |
P/E (TTM) | 28.44 |
Market cap | 11.57bn USD |
EPS (TTM) | 2.26 USD |
Data delayed at least 15 minutes, as of Mar 27 2023 07:04 BST.
More ▼